✦ LIBER ✦

A double-blind comparative study of sertraline and amitriptyline in outpatients with major depressive episodes

✍ Scribed by G. Bersani; V. Rapisarda; N. Ciani; A. Bertolino; G. Sorge

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 442 KB
Volume: 9
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.470090108

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-Blind Comparison of Sertraline

A Double-Blind Comparison of Sertraline and Imipramine in Outpatients with Major Depression: Acute (8 Weeks) and Continuation (16 Weeks) Treatment

✍ J.-P. FOURNIER; R. M. LANE; G. CHOUINARD; D. B. WATSON; M. AMIN; R. A. REMICK; L 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

In a double-blind multicentre trial in patients with major depression, the ecacy and the tolerability of sertraline were compared to those of imipramine, during an 8-week acute treatment phase followed by a 16-week continuation treatment phase in treatment responders. A total of 104 patients who met

Efficacy and tolerability of venlafaxine

Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram

✍ Per Allard; Lars Gram; Kristina Timdahl; Kirsten Behnke; Martin Hanson; Jesper S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract ## Background The objectives of the study were to compare efficacy and tolerability of venlafaxine ER 75–150 mg/day with that of citalopram 10–20 mg/day in elderly patients with major depression according to DSM‐IV criteria. ## Methods A randomised, double‐blind, parallel group 6‐mon

A double-blind dose-finding study of rol

A double-blind dose-finding study of rolipram in patients with major depressive disorder

✍ E. H. Bennie; S. K. Chakravarti; C. M. B. Jarman; K. Khan; D. Master; G. H. Murr 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 2 views

Rolipram improves signal transmission in central noradrenergic neurones with a novel mechanism of action: enhanced noradrenaline (first messenger) synthesis and release, and inhibition of cAMP (second messenger) breakdown. Several comparative trials to prove antidepressant activity are under way. Re

Moclobemide and sertraline in the treatm

Moclobemide and sertraline in the treatment of melancholic and nonmelancholic major depression: a comparative study

✍ M. H. Türkçapar; S. Örsel; E. N. Işcan; A. Akdemir; E. Z. Kiliç; M. H. Özbay 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

The objectives of this study were ®rst to compare the responses to moclobemide and sertraline in melancholic and nonmelancholic major depressive patients and secondly to compare the responses of melancholic and nonmelancholic patients in general. Sixty-three patients, with diagnosis of major depress

Effectiveness and tolerability of mirtaz

Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study

✍ A. Ender Altintoprak; Nabi Zorlu; Hakan Coskunol; Fisun Akdeniz; Gul Kitapcioglu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract ## Objective Studies indicate that serotoninergic and noradrenergic pathophysiological mechanisms may underlie both alcohol abuse/dependence and depressive disorder. The purpose of this study was to evaluate and compare the effectiveness and tolerability of two serotonergic and noradre

A double-blind, multicenter trial compar

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

✍ Lesley M. Arnold; Yili Lu; Leslie J. Crofford; Madelaine Wohlreich; Michael J. D 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder. ## Methods This study was a randomized, double‐blind, placebo‐controlled trial co